CA Stock MarketDetailed Quotes

EDT Spectral Medical Inc

Watchlist
  • 0.470
  • 0.0000.00%
15min DelayMarket Closed Jun 28 16:00 ET
131.32MMarket Cap-7833P/E (TTM)

Spectral Medical Inc Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
64.98%-1.22M
-8.29%-10.72M
26.66%-1.66M
-45.59%-3.24M
21.54%-2.34M
-43.00%-3.5M
-13.78%-9.9M
-13.52%-2.26M
6.24%-2.22M
-19.18%-2.98M
Net income from continuing operations
-265.55%-4.16M
-38.84%-15.66M
-161.89%-6.56M
-8.17%-3.39M
-54.92%-4.58M
57.66%-1.14M
-28.41%-11.28M
1.92%-2.5M
-51.67%-3.14M
-17.22%-2.96M
Operating gains losses
291.24%1.31M
248.67%1.74M
238.27%1.57M
792.31%180K
5,269.23%672K
-11,516.67%-685K
-4,222.22%-1.17M
-3,810.34%-1.13M
58.73%-26K
-127.08%-13K
Depreciation and amortization
5.08%62K
-19.85%218K
-16.92%54K
-11.11%56K
-30.99%49K
-19.18%59K
-7.48%272K
-8.45%65K
-11.27%63K
-1.39%71K
Asset impairment expenditure
----
--600K
----
----
----
----
----
----
--8K
----
Remuneration paid in stock
780.77%177K
24.31%1.49M
-2.08%188K
56.22%339K
938.95%987K
-103.75%-26K
-4.92%1.2M
35.21%192K
97.27%217K
-73.54%95K
Other non cashItems
123.90%609K
161.20%1.31M
51.77%730K
3,800.00%234K
1,066.67%70K
3,785.71%272K
1,685.71%500K
6,771.43%481K
-14.29%6K
-14.29%6K
Change In working capital
139.35%778K
-170.12%-406K
140.30%1.76M
-201.24%-653K
276.81%465K
-269.53%-1.98M
132.95%579K
182.63%732K
250.70%645K
58.65%-263K
-Change in receivables
-270.11%-296K
202.23%870K
154.49%534K
-8.33%22K
-24.73%140K
314.81%174K
-1,647.27%-851K
-370.72%-980K
108.70%24K
-56.64%186K
-Change in inventory
622.22%47K
44.68%-26K
-119.38%-62K
91.88%-16K
8.93%61K
96.02%-9K
7.84%-47K
--320K
-91.26%-197K
-21.13%56K
-Change in prepaid assets
37.78%-359K
-157.60%-345K
-44.25%291K
-32.94%230K
-7,125.00%-289K
-120.23%-577K
223.25%599K
728.92%522K
681.36%343K
93.85%-4K
-Change in payables and accrued expense
66.96%-453K
-117.06%-267K
-8.02%986K
-194.88%-574K
366.15%692K
-1,026.35%-1.37M
352.83%1.57M
473.26%1.07M
326.06%605K
71.92%-260K
-Change in other current assets
----
--0
----
----
----
----
---26K
----
----
----
-Change in other working capital
1,047.94%1.84M
3.48%-638K
105.68%10K
-142.31%-315K
42.32%-139K
-70.18%-194K
-0.76%-661K
14.98%-176K
1.52%-130K
-66.21%-241K
Cash from discontinued investing activities
Operating cash flow
64.98%-1.22M
-8.29%-10.72M
26.66%-1.66M
-45.59%-3.24M
21.54%-2.34M
-43.00%-3.5M
-13.78%-9.9M
-13.52%-2.26M
6.24%-2.22M
-19.18%-2.98M
Investing cash flow
Cash flow from continuing investing activities
-16K
-460.61%-185K
-424.56%-185K
0
0
0
89.85%-33K
5,800.00%57K
-102.94%-69K
89.02%-19K
Net PPE purchase and sale
---16K
-460.61%-185K
-424.56%-185K
--0
--0
--0
89.85%-33K
5,800.00%57K
-102.94%-69K
89.02%-19K
Cash from discontinued investing activities
Investing cash flow
---16K
-460.61%-185K
-424.56%-185K
--0
--0
--0
89.85%-33K
5,800.00%57K
-102.94%-69K
89.02%-19K
Financing cash flow
Cash flow from continuing financing activities
1,196.97%362K
-42.43%5.44M
-102.52%-238K
57,550.00%5.75M
-25.00%-30K
-197.06%-33K
-22.26%9.46M
32,710.34%9.46M
-100.11%-10K
-101.27%-24K
Net issuance payments of debt
0.00%-33K
5.93%3.93M
-162.96%-2.39M
21,386.67%6.39M
-3.45%-30K
-13.79%-33K
3,384.07%3.71M
13,200.00%3.8M
-7.14%-30K
-3.57%-29K
Net common stock issuance
----
--0
----
----
----
----
-59.75%4.03M
----
----
----
Proceeds from stock option exercised by employees
--395K
--0
--0
--0
--0
--0
-97.42%88K
--0
-61.54%20K
-99.74%5K
Net other financing activities
----
-7.35%1.51M
--2.15M
----
----
----
244.51%1.63M
----
----
----
Cash from discontinued financing activities
Financing cash flow
1,196.97%362K
-42.43%5.44M
-102.52%-238K
57,550.00%5.75M
-25.00%-30K
-197.06%-33K
-22.26%9.46M
32,710.34%9.46M
-100.11%-10K
-101.27%-24K
Net cash flow
Beginning cash position
-64.92%2.95M
-5.35%8.41M
322.42%5.03M
-27.26%2.52M
-24.51%4.89M
-5.35%8.41M
53.09%8.89M
-89.10%1.19M
-20.69%3.47M
24.39%6.47M
Current changes in cash
75.11%-878K
-1,047.48%-5.46M
-128.65%-2.08M
209.08%2.51M
21.66%-2.37M
-46.27%-3.53M
-115.16%-476K
459.39%7.26M
-135.45%-2.3M
-287.05%-3.02M
Effect of exchange rate changes
----
----
----
--0
----
----
----
----
-58.73%26K
124.53%13K
End cash Position
-57.55%2.07M
-64.92%2.95M
-64.92%2.95M
322.42%5.03M
-27.26%2.52M
-24.51%4.89M
-5.35%8.41M
-5.35%8.41M
-89.10%1.19M
-20.69%3.47M
Free cash from
64.52%-1.24M
-9.80%-10.91M
16.36%-1.84M
-41.20%-3.24M
22.04%-2.34M
-42.89%-3.5M
-8.16%-9.93M
-6.28%-2.2M
4.70%-2.29M
-11.96%-3M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 64.98%-1.22M-8.29%-10.72M26.66%-1.66M-45.59%-3.24M21.54%-2.34M-43.00%-3.5M-13.78%-9.9M-13.52%-2.26M6.24%-2.22M-19.18%-2.98M
Net income from continuing operations -265.55%-4.16M-38.84%-15.66M-161.89%-6.56M-8.17%-3.39M-54.92%-4.58M57.66%-1.14M-28.41%-11.28M1.92%-2.5M-51.67%-3.14M-17.22%-2.96M
Operating gains losses 291.24%1.31M248.67%1.74M238.27%1.57M792.31%180K5,269.23%672K-11,516.67%-685K-4,222.22%-1.17M-3,810.34%-1.13M58.73%-26K-127.08%-13K
Depreciation and amortization 5.08%62K-19.85%218K-16.92%54K-11.11%56K-30.99%49K-19.18%59K-7.48%272K-8.45%65K-11.27%63K-1.39%71K
Asset impairment expenditure ------600K--------------------------8K----
Remuneration paid in stock 780.77%177K24.31%1.49M-2.08%188K56.22%339K938.95%987K-103.75%-26K-4.92%1.2M35.21%192K97.27%217K-73.54%95K
Other non cashItems 123.90%609K161.20%1.31M51.77%730K3,800.00%234K1,066.67%70K3,785.71%272K1,685.71%500K6,771.43%481K-14.29%6K-14.29%6K
Change In working capital 139.35%778K-170.12%-406K140.30%1.76M-201.24%-653K276.81%465K-269.53%-1.98M132.95%579K182.63%732K250.70%645K58.65%-263K
-Change in receivables -270.11%-296K202.23%870K154.49%534K-8.33%22K-24.73%140K314.81%174K-1,647.27%-851K-370.72%-980K108.70%24K-56.64%186K
-Change in inventory 622.22%47K44.68%-26K-119.38%-62K91.88%-16K8.93%61K96.02%-9K7.84%-47K--320K-91.26%-197K-21.13%56K
-Change in prepaid assets 37.78%-359K-157.60%-345K-44.25%291K-32.94%230K-7,125.00%-289K-120.23%-577K223.25%599K728.92%522K681.36%343K93.85%-4K
-Change in payables and accrued expense 66.96%-453K-117.06%-267K-8.02%986K-194.88%-574K366.15%692K-1,026.35%-1.37M352.83%1.57M473.26%1.07M326.06%605K71.92%-260K
-Change in other current assets ------0-------------------26K------------
-Change in other working capital 1,047.94%1.84M3.48%-638K105.68%10K-142.31%-315K42.32%-139K-70.18%-194K-0.76%-661K14.98%-176K1.52%-130K-66.21%-241K
Cash from discontinued investing activities
Operating cash flow 64.98%-1.22M-8.29%-10.72M26.66%-1.66M-45.59%-3.24M21.54%-2.34M-43.00%-3.5M-13.78%-9.9M-13.52%-2.26M6.24%-2.22M-19.18%-2.98M
Investing cash flow
Cash flow from continuing investing activities -16K-460.61%-185K-424.56%-185K00089.85%-33K5,800.00%57K-102.94%-69K89.02%-19K
Net PPE purchase and sale ---16K-460.61%-185K-424.56%-185K--0--0--089.85%-33K5,800.00%57K-102.94%-69K89.02%-19K
Cash from discontinued investing activities
Investing cash flow ---16K-460.61%-185K-424.56%-185K--0--0--089.85%-33K5,800.00%57K-102.94%-69K89.02%-19K
Financing cash flow
Cash flow from continuing financing activities 1,196.97%362K-42.43%5.44M-102.52%-238K57,550.00%5.75M-25.00%-30K-197.06%-33K-22.26%9.46M32,710.34%9.46M-100.11%-10K-101.27%-24K
Net issuance payments of debt 0.00%-33K5.93%3.93M-162.96%-2.39M21,386.67%6.39M-3.45%-30K-13.79%-33K3,384.07%3.71M13,200.00%3.8M-7.14%-30K-3.57%-29K
Net common stock issuance ------0-----------------59.75%4.03M------------
Proceeds from stock option exercised by employees --395K--0--0--0--0--0-97.42%88K--0-61.54%20K-99.74%5K
Net other financing activities -----7.35%1.51M--2.15M------------244.51%1.63M------------
Cash from discontinued financing activities
Financing cash flow 1,196.97%362K-42.43%5.44M-102.52%-238K57,550.00%5.75M-25.00%-30K-197.06%-33K-22.26%9.46M32,710.34%9.46M-100.11%-10K-101.27%-24K
Net cash flow
Beginning cash position -64.92%2.95M-5.35%8.41M322.42%5.03M-27.26%2.52M-24.51%4.89M-5.35%8.41M53.09%8.89M-89.10%1.19M-20.69%3.47M24.39%6.47M
Current changes in cash 75.11%-878K-1,047.48%-5.46M-128.65%-2.08M209.08%2.51M21.66%-2.37M-46.27%-3.53M-115.16%-476K459.39%7.26M-135.45%-2.3M-287.05%-3.02M
Effect of exchange rate changes --------------0-----------------58.73%26K124.53%13K
End cash Position -57.55%2.07M-64.92%2.95M-64.92%2.95M322.42%5.03M-27.26%2.52M-24.51%4.89M-5.35%8.41M-5.35%8.41M-89.10%1.19M-20.69%3.47M
Free cash from 64.52%-1.24M-9.80%-10.91M16.36%-1.84M-41.20%-3.24M22.04%-2.34M-42.89%-3.5M-8.16%-9.93M-6.28%-2.2M4.70%-2.29M-11.96%-3M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
%Chg